# LYPQOZET
> **ANDA206084** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2017-04-26
## Drug
- **FDA Application Number:** ANDA206084
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LYPQOZET
- **Generic name:** Atorvastatin Calcium
- **Active ingredients:** ATORVASTATIN CALCIUM; EZETIMIBE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2017-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206084)
---
*AI Analytics · CC0 1.0*